Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1985 1
1987 1
1988 4
1989 9
1990 8
1991 5
1992 9
1993 11
1994 12
1995 9
1996 19
1997 11
1998 11
1999 20
2000 17
2001 13
2002 17
2003 34
2004 25
2005 23
2006 38
2007 28
2008 25
2009 39
2010 53
2011 65
2012 65
2013 70
2014 89
2015 107
2016 96
2017 75
2018 93
2019 155
2020 193
2021 243
2022 249
2023 24
Text availability
Article attribute
Article type
Publication date

Search Results

1,774 results
Results by year
Filters applied: . Clear all
Page 1
Rising incidence of early-onset colorectal cancer - a call to action.
Akimoto N, Ugai T, Zhong R, Hamada T, Fujiyoshi K, Giannakis M, Wu K, Cao Y, Ng K, Ogino S. Akimoto N, et al. Among authors: zhong r. Nat Rev Clin Oncol. 2021 Apr;18(4):230-243. doi: 10.1038/s41571-020-00445-1. Epub 2020 Nov 20. Nat Rev Clin Oncol. 2021. PMID: 33219329 Free PMC article. Review.
Sorting nexin 5 mediates virus-induced autophagy and immunity.
Dong X, Yang Y, Zou Z, Zhao Y, Ci B, Zhong L, Bhave M, Wang L, Kuo YC, Zang X, Zhong R, Aguilera ER, Richardson RB, Simonetti B, Schoggins JW, Pfeiffer JK, Yu L, Zhang X, Xie Y, Schmid SL, Xiao G, Gleeson PA, Ktistakis NT, Cullen PJ, Xavier RJ, Levine B. Dong X, et al. Among authors: zhong r. Nature. 2021 Jan;589(7842):456-461. doi: 10.1038/s41586-020-03056-z. Epub 2020 Dec 16. Nature. 2021. PMID: 33328639 Free PMC article.
Osimertinib in EGFR-Mutated Lung Cancer.
Liang W, Zhong R, He J. Liang W, et al. Among authors: zhong r. N Engl J Med. 2021 Feb 18;384(7):675. doi: 10.1056/NEJMc2033951. N Engl J Med. 2021. PMID: 33596364 No abstract available.
Immune-Mediated Diseases Associated With Cancer Risks.
He MM, Lo CH, Wang K, Polychronidis G, Wang L, Zhong R, Knudsen MD, Fang Z, Song M. He MM, et al. Among authors: zhong r. JAMA Oncol. 2022 Feb 1;8(2):209-219. doi: 10.1001/jamaoncol.2021.5680. JAMA Oncol. 2022. PMID: 34854871 Free PMC article.
Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer.
Liang W, Cai K, Chen C, Chen H, Chen Q, Fu J, Hu J, Jiang T, Jiao W, Li S, Liu C, Liu D, Liu W, Liu Y, Ma H, Pan X, Qiao G, Tian H, Wei L, Zhang Y, Zhao S, Zhao X, Zhou C, Zhu Y, Zhong R, Li F, Rosell R, Provencio M, Massarelli E, Antonoff MB, Hida T, de Perrot M, Lin SH, Di Maio M, Rossi A, De Ruysscher D, Ramirez RA, Dempke WCM, Camidge DR, Guibert N, Califano R, Wang Q, Ren S, Zhou C, He J. Liang W, et al. Among authors: zhong r. Transl Lung Cancer Res. 2020 Dec;9(6):2696-2715. doi: 10.21037/tlcr-2020-63. Transl Lung Cancer Res. 2020. PMID: 33489828 Free PMC article. Review. No abstract available.
Toxicity profile of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung cancer: A systematic review and network meta-analysis.
Zhao Y, Cheng B, Chen Z, Li J, Liang H, Chen Y, Zhu F, Li C, Xu K, Xiong S, Lu W, Chen Z, Zhong R, Zhao S, Xie Z, Liu J, Liang W, He J. Zhao Y, et al. Among authors: zhong r. Crit Rev Oncol Hematol. 2021 Apr;160:103305. doi: 10.1016/j.critrevonc.2021.103305. Epub 2021 Mar 20. Crit Rev Oncol Hematol. 2021. PMID: 33757838 Review.
PD-L1 expression and Tumor mutation burden as Pathological response biomarkers of Neoadjuvant immunotherapy for Early-stage Non-small cell lung cancer: A systematic review and meta-analysis.
Deng H, Zhao Y, Cai X, Chen H, Cheng B, Zhong R, Li F, Xiong S, Li J, Liu J, He J, Liang W. Deng H, et al. Among authors: zhong r. Crit Rev Oncol Hematol. 2022 Feb;170:103582. doi: 10.1016/j.critrevonc.2022.103582. Epub 2022 Jan 11. Crit Rev Oncol Hematol. 2022. PMID: 35031441 Review.
1,774 results